deltatrials
Terminated EARLY_PHASE1 INTERVENTIONAL 2-arm NCT05458375

Vaginal Estradiol Use in Pessary Care

Vaginal Estradiol Use in Pessary Management: A Randomized Controlled Trial

Sponsor: University of South Florida

Updated 5 times since 2022 Last updated: May 9, 2023 Started: Dec 29, 2022 Primary completion: Apr 26, 2023 Completion: Apr 26, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

There is a lack of potential study participants at our study site that would meet inclusion criteria, therefore, the study is not feasible and is being terminated.

A EARLY_PHASE1 clinical study on Pelvic Organ Prolapse and Pessary Ulcer of Vagina, this trial is terminated or withdrawn. The trial is conducted by University of South Florida and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Jun 2023 · 7 months · monthly snapshotNot Yet Recruiting~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated EARLY_PHASE1

  3. Jun 2023 — Jul 2024 [monthly]

    Terminated EARLY_PHASE1

    Status: Not Yet RecruitingTerminated

  4. Nov 2022 — Jun 2023 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  5. Sep 2022 — Nov 2022 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of South Florida
Data source: University of South Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations